Skip to content
Biophytis
LIVE HEALTHIER LONGER
Biophytis
  • Corporate
    • Executive Committee
    • Scientific Advisory Board
    • Boards of Directors
    • Code of Ethics
  • Our Science
    • BIO101
      • Posters & Publications
        • 2024
        • 2023
        • 2022
        • 2021
        • 2020
        • 2019
        • 2018
        • 2017
        • 2016
        • 2015
        • 2014
    • Macuneos (BIO201)
      • Posters & Publications
  • Pipeline
    • Pipeline
    • Key milestones in the development of BIO101
    • Sarcopenia: SARA clinical program
    • Obesity: OBA Clinical Program
    • COVID-19: COVA clinical program
    • Duchenne Muscular Dystrophy: MYODA clinical program
    • Age-related Macular Degeneration: MACA clinical program
  • Investors
    • Letter to shareholders
    • Live Stock Price
    • Corporate Presentation
    • General Meetings
      • 2024
      • 2023
      • 2022
      • 2021
      • 2020
    • AMF Regulated Information
    • SEC Filings
    • Financial Calendar
    • Convertible bonds
  • News
    • Press Releases
      • 2025
      • 2024
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
    • Biophytis in Media
  • Recruitment
  • Contact
    • Contact
    • Contact Information
    • Legal information
  • LinkedIn
  • Twitter
  • FR
  • EN
  • Corporate
    • Executive Committee
    • Scientific Advisory Board
    • Boards of Directors
    • Code of Ethics
  • Our Science
    • BIO101
      • Posters & Publications
        • 2024
        • 2023
        • 2022
        • 2021
        • 2020
        • 2019
        • 2018
        • 2017
        • 2016
        • 2015
        • 2014
    • Macuneos (BIO201)
      • Posters & Publications
  • Pipeline
    • Pipeline
    • Key milestones in the development of BIO101
    • Sarcopenia: SARA clinical program
    • Obesity: OBA Clinical Program
    • COVID-19: COVA clinical program
    • Duchenne Muscular Dystrophy: MYODA clinical program
    • Age-related Macular Degeneration: MACA clinical program
  • Investors
    • Letter to shareholders
    • Live Stock Price
    • Corporate Presentation
    • General Meetings
      • 2024
      • 2023
      • 2022
      • 2021
      • 2020
    • AMF Regulated Information
    • SEC Filings
    • Financial Calendar
    • Convertible bonds
  • News
    • Press Releases
      • 2025
      • 2024
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
    • Biophytis in Media
  • Recruitment
  • Contact
    • Contact
    • Contact Information
    • Legal information
  • LinkedIn
  • Twitter
  • FR
  • EN

Category Archives: Press Releases

February 21, 2017

Press ReleasesBy Antoine21 February 2017

Biophytis relocates to Pierre and Marie Curie University (UPMC) campus and solidifies creation of leading translational platform for age-related disease. Read the Press Release

January 05, 2017

Press ReleasesBy Antoine5 January 2017

BIOPHYTIS to participate to the JP Morgan Annual Healthcare Conference in San Francisco, January 9-12th 2017. Read the Press Release.

December 16, 2016

Press ReleasesBy Antoine16 December 2016

Biophytis presents preliminary clinical data of SARA-PK, and new preclinical data of Sarconeos for treating sarcopenia. Read the Press Release

November 29, 2016

Press ReleasesBy Antoine29 November 2016

BIOPHYTIS Announces Successful Completion of SARA-PK Clinical Study for Sarconeos in Sarcopenia Confirming Safety Profile. Read the Press Release

November 28, 2016

Press ReleasesBy Antoine28 November 2016

Conférence Biotech Agora – December 13, 2016 18h45 – Hôtel ATALA, 10 Rue de Chateaubriand, 75008

november 22, 2016

Press ReleasesBy Antoine22 November 2016

BIOPHYTIS received regulatory authorizations to conduct SARA-OBS study in sarcopenia patients. Read the Press Release

November 15, 2016

Press ReleasesBy Antoine15 November 2016

Biophytis Presenting Four Posters on Sarconeos at 9th International Conference on Cachexia, Sarcopenia, and Muscle Wasting. Read the Press Release

November 09, 2016

Press ReleasesBy Antoine9 November 2016

BIOPHYTIS to attend to Jefferies conference (London) and European Midcap event (Geneva). Read the Press Release

October 24, 2016

Press ReleasesBy Antoine24 October 2016

BIOPHYTIS chooses Patheon to produce the clinical batches of Macuneos, its AMD drug candidate that will enter Phase 2B. Read the Press Release

October 11, 2016

Press ReleasesBy Antoine11 October 2016

BIOPHYTIS to implement company’s SARA-data e-Health platform for clinical development of Sarconeos in sarcopenia patients. Read the Press Release

←1
23456789101112131415161718192021222324252627
…282930313233→
© Biophytis 2006-2025 - Mentions Légales
  • Corporate
    • Executive Committee
    • Scientific Advisory Board
    • Boards of Directors
    • Code of Ethics
Footer Colonne 1 - Anglais
Go to Top
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok